The autoimmune disease diagnosis market is experiencing significant growth due to the high incidence of autoimmune diseases, increasing awareness about autoimmune diseases, and the growth in research on autoimmune diseases.

What the market looks like?

The global autoimmune disease diagnosis market size is expected to grow from USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519

Consumables & assay kits segment to dominate the autoimmune disease diagnosis market:

The consumables & assay kits segment is expected to grow at the highest growth rate during the forecast period. This is attributed primarily to the rising incidence of autoimmune disease and the increasing number of product launches/approvals.

Routine laboratory tests segment:

Based on the test type, the autoimmune disease diagnosis industry is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. The routine laboratory tests segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing prevalence of autoimmune diseases coupled with advanced healthcare infrastructure in the region.

Growth Trends and Strategic Analysis of Largest Revenue Generating Region:

The autoimmune disease diagnosis market has been analyzed for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, Europe held the largest share of the market, followed by Asia Pacific. The rising incidences of chronic diseases, the increasing geriatric population in this region are the major factors driving the growth of the autoimmune disease diagnosis industry in Europe.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=174826519

Key Players in Autoimmune Disease Diagnosis Market:

The prominent players operating in autoimmune disease diagnosis market include Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU GROUP GMBH & CO. KG (Germany).